HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

dacetuzumab

anti-CD40 antibody for treating hematological cancers
Also Known As:
HU-S2C6; HUS2C6; SGN 40; SGN-40; SGN40 cpd; hu S2C6
Networked: 22 relevant articles (1 outcomes, 9 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Drachman, Jonathan G: 6 articles (01/2015 - 09/2009)
2. Forero-Torres, Andres: 6 articles (01/2015 - 09/2009)
3. Advani, Ranjana: 5 articles (01/2015 - 03/2009)
4. Grewal, Iqbal S: 4 articles (07/2011 - 09/2005)
5. Furman, Richard R: 3 articles (06/2014 - 09/2009)
6. Whiting, Nancy: 3 articles (03/2011 - 09/2009)
7. Ansell, Stephen M: 2 articles (01/2015 - 06/2014)
8. Bartlett, Nancy L: 2 articles (01/2015 - 06/2014)
9. Whiting, Nancy C: 2 articles (06/2014 - 02/2013)
10. de Vos, Sven: 2 articles (06/2014 - 03/2011)

Related Diseases

1. Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
2. B-Cell Lymphoma (Lymphoma, B Cell)
3. Lymphoma (Lymphomas)
4. Multiple Myeloma
5. Non-Hodgkin Lymphoma (Lymphosarcoma)

Related Drugs and Biologics

1. Monoclonal Antibodies
2. dacetuzumab
3. Immunoglobulin G (IgG)
4. Rituximab (Mabthera)
5. Carboplatin (JM8)
6. Vincristine (Oncovin)
7. Prednisolone (Predate)
8. Ifosfamide
9. Etoposide (VP 16)
10. Doxorubicin (Adriamycin)

Related Therapies and Procedures

1. Salvage Therapy
2. Therapeutics